The overt physiological expression of the interaction between a ligand and its receptor on a cell surface is the product of two distinct steps-the formation of the ligand-receptor complex, and the transmission of the relevant message into the cell interior. The accessibility of surface receptors to ligand binding can be modulated by changes in the membrane lipid fluidity which, in turn, may mediate a shift in the equilibrium position of membrane proteins (1-4). Signal transduction, either through activation of adenylate cyclase by the ligand-receptor complex (5, 6) or by microaggregation of ligand-receptor complexes (7, 8) , is associated with lateral movements of components of the membrane which are determined, at least partially, by lipid fluidity (9). This net "passive" modulation of a receptor function by lipid fluidity is therefore a rapid physical process which does not require metabolic energy. It has been suggested (10) that this mechanism may play a key role in the modulation of receptor function in fast cellular processes such as neurotransmission.
increased by in vitro incubation with eitler cholesteryl hemisuccinate or stearic acid, resulting in an up to 5- accessibility. These results may have important implications for physiological processes in the central nervous system, which are associated with modulation of membrane lipids, such as aging. In addition, the regional heterogeneity and plasticity of receptors may be accounted for by differences in membrane lipid fluidity. It was found here that various brain regions differ markedly in their membrane lipid viscosity.
The overt physiological expression of the interaction between a ligand and its receptor on a cell surface is the product of two distinct steps-the formation of the ligand-receptor complex, and the transmission of the relevant message into the cell interior. The accessibility of surface receptors to ligand binding can be modulated by changes in the membrane lipid fluidity which, in turn, may mediate a shift in the equilibrium position of membrane proteins (1) (2) (3) (4) . Signal transduction, either through activation of adenylate cyclase by the ligand-receptor complex (5, 6) or by microaggregation of ligand-receptor complexes (7, 8) , is associated with lateral movements of components of the membrane which are determined, at least partially, by lipid fluidity (9). This net "passive" modulation of a receptor function by lipid fluidity is therefore a rapid physical process which does not require metabolic energy. It has been suggested (10) that this mechanism may play a key role in the modulation of receptor function in fast cellular processes such as neurotransmission.
The accessibility of a receptor binding site, which is a prerequisite for its function, and the extent and direction of its displacement by changes in the lipid fluidity are determined primarily by the geometry of the receptor in the immediate lipid environment. The 3-adrenergic receptor, for example, is affected by lipid fluidity in a different manner in different cells. When lipid microviscosity is decreased, the receptor be- (14) was used, in order to avoid using ethanol. CholSuc was dissolved in glacial acetic acid (40 mg/ml) by heating and stirring. The hot solution was diluted to 100 vol with 50 mM Tris-HCI, pH 7.4/3.5% PVP, with vigorous stirring. The pH was then readjusted to 7.4 with solid Tris base. The resulting translucent suspension of CholSuc in 170 mM Tris acetate buffer was then used for modulating membrane fluidity. Solutions of egg lecithin (80 mg/ml), stearic acid (6 mg/ml), and linoleic acid (6 mg/ml) in glacial acetic acid were used in a similar manner to form the corresponding media.
Crude Membrane Preparation (Crude Homogenate). Male BALB mice (20-25 g; 6-8 weeks old) were decapitated, and their forebrains (whole brain minus cerebellum) were rapidly removed and homogenized in 20 vol of ice-cold 50 mM Tris-HCI (pH 7.4) buffer in an Ultra-Turrax homogenizer (setting 6, 20 sec). The homogenates were then centrifuged at 42,000 X g for 10 min at 4°C in a Sorvall RC-5B centrifuge. The pellets were resuspended in 10 vol of the same buffer (100 mg of tissue per ml) and incubated for 2 hr with varying volumes of the lipid suspensions described above. Between 1 and 30 ml of lipid Abbreviations: CholSuc, cholesteryl hemisuccinate; PVP, polyvinylpyrrolidone; SPM, synaptic plasma membranes. f To whom correspondence should be addressed.
suspension per 1 ml of membrane suspension, at room temperature, with continuous shaking, was used. The samples were then centrifuged at 42,000 X g for 10 min, and the pellets were washed twice with 10-20 vol of 50 mM Tris-HCI (pH 7.4) buffer. The final pellet was resuspended in 50 vol of 50 mM Tris.HCI (pH 7.4) buffer containing 0.1 mM pargyline and 0.2 mg of ascorbate per ml and used for [3H]serotonin binding assays (as described below).
Crude Synaptosomal Membrane Preparation. Crude synaptosomal membranes were prepared as described (15) . The resulting pellet was suspended in 10 vol (based on original tissue weight) of 50 mM Tris.HCI (pH 7.4) buffer and subjected to lipid treatment, as described above for the crude membrane preparation. Washing and final resuspension with ascorbate and pargyline were as described above.
As controls, each preparation was incubated for 2 hr with either 10 vol of 50 mM Tris.HCI (pH 7.4) buffer or 10 vol of 170 mM Tris acetate (pH 7.4) buffer, containing 3.5% PVP and then washed and resuspended as described above. No significant differences in serotonin binding or in membrane fluidity were found after incubation in these buffers.
Synaptic Plasma Membrane (SPM) Preparation. SPM were prepared as described (16) . The final pellet, containing SPM, was weighed, suspended in 10 vol of 50 mM Tris-HCI (pH 7.4) buffer, and subjected to lipid treatment as described above. This preparation was used for membrane fluidity determinations only.
[3H]Serotonin Binding Assay. This assay was performed as described (17, 18) , with minor modifications, because endogenous serotonin in the samples used was assumed to be degraded completely after the 2-hr lipid treatment (19) . All assays were done in triplicate, together with triplicates containing unlabeled serotonin. Specific binding is defined as the total minus the nonspecific binding-i.e., in the presence of 10 MM unlabeled serotonin.
Measurements of Lipid Fluidity. Membrane lipid microviscosity i was determined by fluorescence depolarization of a lipid probe, 1,6-diphenyl-1,3,5-hexatriene (for review, see ref. 20) . A stock solution of 2 mM diphenylhexatriene in tetrahydrofuran was diluted 1:1000 into vigorously stirred phosphate-buffered saline (pH 7.2). A sample of membranes (containing about 40 ,ug of protein) was suspended in 2 ml of the diphenylhexatriene dispersion and incubated for 30 min at 250C. The degree of fluorescence polarization, P, was then recorded at 250C as described (21) . The lipid microviscosity (the reciprocal of fluidity) was estimated by the approximate empirical relation, i = 2P/(0.46 -P) which, on a relative scale, should be close to linear (20) . Preliminary observations showed that CholSuc had a greater effect than cholesterol on lipid fluidity; therefore, CholSuc was selected as the membrane rigidifier (14) to be used in this study. [3H]serotonin binding increased markedly with increasing microviscosity and binding decreased slightly, although significantly, with an increase in membrane fluidity. The nonspecific binding, constituting 40-50% of the total binding, varied linearly with ligand concentration and also increased as i7 increased, although to a much smaller extent than the total binding (data not shown). Fig. 2 shows the same data as in Fig. 1 , replotted according to Scatchard (22 [3H]serotonin binding are presented in Fig. 3 . In both figures, the control curves are nonlinear, indicating two types of binding sites. (18, 19) . The capacity and Kd of both high-and low-affinity sites increased progressively with increasing i-. At high values of -, the difference between the slopes of high-and low-affinity sites seemed to vanish, with a clear trend toward the expression of Table 3 presents i values of membranes obtained from different brain regions of BALB mice and other rodent species. Although these measurements were made on crude preparations, the data indicate a wide range of lipid microviscosity of the membranes from different brain regions as well as from different species. The data also indicate that the fluidity values, obtained after the various lipid treatments, are within the range obtained for untreated preparations.
In order to exclude the possibility that the effects on binding seen when membrane microviscosity was changed were due to bertain specific lipids (such as CholSuc and lecithin), both preparations were treated with stearic acid (which has a rigidifying effect) and linoleic acid (with a lecithin-like fluidizing effect). Both stearic and linoleic acids had effects on membrane fluidity and [3H]serotonin binding similar to those due to treatment with CholSuc and lecithin, respectively (see Fig. 4 ). Excess CholSuc was found to coprecipitate with the membranes, thus contributing, at least in part, to the increase in nonspecific binding observed in CholSuc-treated membranes.
The reversibility of the changes in binding described above was confirmed by a two-stage treatment. The sample was first treated with lecithin, and the expected decrease in and in binding was observed. Further treatment with CholSuc caused a reversal of these changes. We have also carried out this procedure in the opposite direction (23 (Fig. 4) (23) .
The results in Table 2 confirm that the new sites satisfy the definition of serotonin receptors because the substrate speci- Table 1 ) may have an alternative explanation. The low-and high-affinity sites may be located at different levels along the vertical axis of the receptor molecule. As the latter is displaced vertically to the plane of the membrane, the relative contribution of each of these sites is changed as indicated by the Scatchard plot parameters.
One of the most interesting findings presented in this study is that, under normal physiological conditions, the apparent binding capacity of serotonin receptors constitutes only about 20% of the potential binding capacity stored in the membrane (Fig. 4) . Obviously, the binding of an agonist to a receptor is just the initial step in a sequence of events. The next step, which is the activation of adenylate cyclase, is probably enhanced by increasing lipid fluidity (9, 13) . The final response of target cells of different membrane fluidity therefore could be the result of two opposing processes-the accessibility of receptors, which decreases with lipid fluidity, and the activation of adenylate cyclase, which increases with lipid fluidity. For maximal response, one therefore may expect an optimal lipid fluidity for each receptor. Other processes involved in synaptic transmission, such as release and reuptake, may also change in response to changes in membrane lipid fluidity.
The increase in the lipid viscosity of synaptic membranes from the brains of aged animals (Table 3 ) could initially increase receptor accessibility. It has been reported (24) that the number of serotonin binding sites in brains from old men is about 2-fold higher than in brains from young adults, and only low-affinity sites are found. However, the overexposed receptors can overshoot the point of optimal activity and eventually become more vulnerable to degradation. Some of the behavioral aspects of aging, associated with the serotoninergic system (e.g., loss of sleep, appetite, and libido), could be accounted for by this process. Table 3 shows that membranes prepared from various brain regions differ in their fluidity. This might be a partial explanation of the heterogeneity of receptor sites in the brain. Consistent with our findings that midbrain is composed of more viscous membranes compared to cerebral cortex and hippocampus (with more fluid membranes), Bennet and Snyder (17) have shown that Kd of [3H]serotonin is lower (higher affinity) in cortex and hippocampus as compared to midbrain. We have also observed that the binding of 3H-labeled [D-ala]enkephalin and [3H]naloxone to the opiate receptor is modulated by changes in membrane lipid fluidity (23) .
The changes in binding of transmitters, agonists, and antagonists, as well as in synaptic plasticity, may be associated with modulation of membrane architecture caused by changes in lipid fluidity.
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